Microbe-based process for GBL nears commercialization
Scott Jenkins
Metabolix Inc. (Cambridge, Mass.; www.metabolix.com) has successfully demonstrated and completed research and development for scaleup on a fermentation process that produces gamma -butyrolactone (GBL) from genetically engineered bacteria. The process is built...
This information is only available to Gold members.
Forgot your user ID or password? Click here to have it sent to you.
Not a member yet?
UPGRADE now to full archive accces and you will receive:
A discount on full delegate pass to ChemInnovations.
Join other CPI professionals from all over the globe and share best practices, expertise, concerns and more.
Provide feedback to Chemical Engineering Editors
Current members represent Worley Parsons, DuPont, SABIC, Fluor, Air Products, LyondellBasell, Nalco, Dow Chemical, Dow Corning, BASF, Jacobs Engineering, ExxonMobil, Shell, Chevron and more.
